3,373 results match your criteria: "Controversies in Prostate Cancer"
Quant Imaging Med Surg
December 2024
Department of Urology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
Background: Addition of magnetic resonance imaging (MRI) in prostate cancer screening remains controversial issue. Despite the increased utilization of MRI, several studies have revealed its potential suboptimal diagnostic efficacy in young patients. This study aimed to further substantiate the limited diagnostic efficiency of MRI positivity [defined as Prostate Imaging Reporting and Data System (PI-RADS) scores ≥3] among young individuals aged ≤55 years suspected of prostate cancer, and more significantly, to evaluate two proposed approaches.
View Article and Find Full Text PDFTransl Androl Urol
November 2024
Department of Urology, Singapore General Hospital, SingHealth, Singapore, Singapore.
Background: Management of localised prostate cancer (PCa) remains controversial in the era of prostate-specific antigen (PSA) testing. This study aims to describe the natural history of men with PCa being followed up expectantly to evaluate disease mortality.
Methods: After exclusion, clinical data of 204 patients retrieved from a prospective large PCa registry were reviewed.
Biol Res
December 2024
Centro de Biología Celular y Biomedicina CEBICEM, Facultad de Medicina y Ciencia, Universidad San Sebastián, Lota 2465, Providencia., Santiago, 7510156, Chile.
Connexins (Cxs) have the ability to form channels that allow the exchange of ions/metabolites between adjacent cells (gap junction channels, GJC) or between the intra- and extra-cellular compartments (hemichannels, HC). Cxs were initially classified as tumor suppressors. However, more recently, it has been shown that Cxs exert anti- and pro-tumorigenic effects depending on the cell and tissue context.
View Article and Find Full Text PDFClin Transl Radiat Oncol
January 2025
Northern Sydney Cancer Centre, Radiation Oncology Unit, Royal North Shore Hospital, St Leonards, Sydney, NSW, Australia.
Background: Nodal only recurrence post radical prostatectomy (RP) is increasingly recognised in the PSMA scan era. Management is controversial with a curative approach usually incorporating prostate bed and nodal irradiation (PB + NRT) in combination with long-term hormonal therapy. It is unknown whether omitting prostate-bed irradiation (PBRT) is safe in a subgroup of these patients.
View Article and Find Full Text PDFCurr Opin Infect Dis
November 2024
Department of Urology, Yale School of Medicine, New Haven, Connecticut, USA.
Int J Clin Oncol
December 2024
Department of Urology, Kyoto University School of Medicine, 54 Shougoinkawahara-Cho, Sakyo-Ku, Kyoto, 606-8507, Japan.
Urologie
November 2024
Klinik für Urologie, Universitätsklinik Düsseldorf, Heinrich-Heine-Universität, Moorenstr. 5, 40225, Düsseldorf, Deutschland.
Background: Population-based screening for prostate cancer (PC) is still controversially discussed. Furthermore, an organized, risk-adapted screening program is already being called for across Europe. Although large randomized controlled trials have shown that prostate-specific antigen (PSA)-based screening can significantly reduce PC-specific mortality, all known screening strategies still frequently lead to overdiagnosis and consecutively to overtreatment of clinically insignificant PC.
View Article and Find Full Text PDFSemin Ultrasound CT MR
November 2024
Associate Professor - Department of Imaging, Oncology and Hematology - Ribeirao Preto School of Medicine - University of Sao Paulo - Brazil. Electronic address:
Prostate Cancer Prostatic Dis
November 2024
Division of Surgery and Interventional Science, University College London, London, UK.
Background: Serum PSA and digital rectal examination remain the key diagnostic tools for detecting prostate cancer. However, due to the limited specificity of serum PSA, the applicability of this marker continues to be controversial. Recent use of image-guided biopsy along with pathological assessment and the use of biomarkers has dramatically improved the diagnosis of clinically significant cancer.
View Article and Find Full Text PDFPostgrad Med J
November 2024
Department of Urology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou Medical University, No. 2 Renmin Street, Section 5, Guta District, Jinzhou, 121002, Liaoning, China.
Objective: Our aim is to explore the relation between benign prostatic hyperplasia (BPH) and prostate cancer (PCa) from a genetic level utilizing Mendelian randomization (MR).
Methods: The IEU genome-wide association studies database was surveyed for single nucleotide polymorphisms (SNPs) associated with BPH, PCa, and PCa (validation cohort). Single nucleotide polymorphisms were subjected to stringent quality control based on rigorous screening criteria.
Front Oncol
October 2024
Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry, Department of Clinical Pharmacy and Pharmacy Administration, West China School of Pharmacy, Sichuan University, Chengdu, China.
Neoplasia
December 2024
Department of Clinical Biochemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz 85-092, Poland. Electronic address:
World J Mens Health
September 2024
Department of Urology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.
There has been much controversy about the effectiveness of prostate cancer (PC) screening in the treatment of PC. Recently, with the increase in advanced and metastatic PCs, prostate-specific antigen (PSA) screening is again emphasized. However, no systematic study has examined the factors influencing PSA screening behavior.
View Article and Find Full Text PDFInt J Urol
October 2024
Department of Urology, Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan.
Eur Urol
October 2024
Onkozentrum Zurich, University of Zurich and Tumorzentrum Hirslanden Zurich, Zurich, Switzerland.
Front Immunol
October 2024
Department of Surgery, First People's Hospital of Kunming City & Calmette Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China.
Front Oncol
September 2024
Department of Nursing, Chang Gung University of Science and Technology, Chiayi, Taiwan.
Tumori
December 2024
Genitourinary Medical Oncology, Prostate Cancer Program, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Genitourinary cancers present significant challenges to oncologists, necessitating innovative approaches for improved patient outcomes. The 'Controversies in Genitourinary Cancers' congress, held in January 2024, convened international experts to address the complexities of prostate, bladder, renal and rare genitourinary cancers. Sessions explored current trends, novel treatments, and unmet needs, emphasizing collaborative efforts to advance knowledge and patient care.
View Article and Find Full Text PDFProstate Cancer Prostatic Dis
October 2024
Department of Urology and Duke Cancer Institute, Duke Medical Center, Durham, NC, USA.
Background: to date, no standardized, evidence-based follow-up schemes exist for the monitoring of patients who underwent focal therapy (FT) and expert centers rely mainly on their own experience and/or institutional protocols. We aimed to perform a comprehensive review of the most advantageous follow-up strategies and their rationale after FT for prostate cancer (PCa).
Methods: a narrative review of the literature was conducted to investigate different follow-up protocols of FT for PCa.
Curr Urol Rep
October 2024
Division of Urology, Department of Surgery, Baylor Scott & White Health, Temple, TX, USA.
J Urol
January 2025
Sexual & Reproductive Medicine Program, Urology Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer Drug Resist
August 2024
Laboratory of Molecular Cancer Biology, URPhyM, NARILIS, University of Namur, Namur 5000, Belgium.
The gene encodes several isoforms, including two transporters (i.e., ABCB5FL, ABCB5β) and several soluble proteins, such as ABCB5α which has been hypothesized to have a regulatory function.
View Article and Find Full Text PDFGeroscience
September 2024
Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
This comprehensive review examines the role of coffee consumption in promoting healthy aging and its potential impact on cancer prevention. Previous research has shown that moderate coffee intake may contribute to extending healthspan and enhancing longevity through beneficial effects on cardiometabolic health and key biological processes involved in aging. However, the relationship between coffee consumption and cancer risk remains controversial.
View Article and Find Full Text PDF